| Market Cap | ₹101Cr |
| ROE | 5.87% |
| P/E Ratio(TTM) | 26.73 |
| EPS(TTM) | 31.43 |
| P/B Ratio | 1.88 |
| Dividend Yield | 0.42% |
| Industry P/E | 39.94 |
| Book Value | 446.41 |
| Debt to Equity | 0.10 |
| Face Value | 10 |
| Parent Organisation | Mercury Labs Limited |
| Managing Director | Mr. Rajendra Shah |
| BSE Symbol | 538964 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.50 | ||
| Ajanta Pharma | NA (0.00%) | 33.07 | ||
| Gland Pharma | NA (0.00%) | 38.55 | ||
| Eris Lifesciences | NA (0.00%) | 52.89 |